Stocks / NASDAQ / MYOS RENS Technology Inc.

MYOS RENS Technology Inc.

Our Opinion

MYOS RENS Technology Inc. is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

“This study investigated the impact of Fortetropin® on protein synthesis and markers of protein degradation in rats after acute exercise.” Read the following article

Company Description

MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of therapeutic products, nutritional supplements, and other technologies aimed at improving the health and performance of muscle tissue. The firm offers bionutrition products and biotherapeutic research. Bionutrition products involves Re Muscle Health, which seeks to rebuild, rejuvenate, and maintain lean muscles. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. [Source: MarketWatch]

Company Website: